Botulinum Toxin Treatment for Upper Lid Retraction of Dysthyroidism

Journal of the Medical Association of Thailand

Volumn 86, Issue 11, 2003, Pages 1051-1054

  Chuenkongkaew, Wanicha ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Botulinum toxin; Dysthyroidism; Upper eyelid retraction

Indexed keywords

BOTULINUM TOXIN;

ADULT; ARTICLE; CLINICAL ARTICLE; ENDOCRINE OPHTHALMOPATHY; EUTHYROIDISM; EYELID DISEASE; EYELID RETRACTION; FEMALE; HUMAN; MALE; SIDE EFFECT; THAILAND;

ADULT; BOTULINUM TOXINS; DRUG ADMINISTRATION SCHEDULE; EYELID DISEASES; EYELIDS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; THYROID DISEASES; TREATMENT OUTCOME;

EID: 0346881614     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Hedin A. Eyelid surgery in dysthyroid ophthalmopathy. Eye 1988; 2: 201-6.
2. Grove AS Jr. Upper eyelid retraction and Graves' disease. Ophthalmology 1981; 88: 499-506.
3. Scott AB, Rosenbaum A, Collins CL. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 1973; 12: 924-7.
4. Kirkness CM, Adams GGW, Dally PN, Lee JP. Botulinum toxin A induced protective ptosis in corneal disease. Ophthalmology 1988; 95: 474-80.
5. Scott AB. Injection treatment of endocrine orbital myopathy. Doc Ophthalmol 1984; 58: 141-5.
6. Ebner R. Botulinum toxin type A in upper lid retraction of Graves' ophthalmopathy. J Clin Neuroophthalmol 1993; 13: 258-61.
7. Biglan AW. Control of eyelid retraction associated with Graves' disease with botulinum A toxin. Ophthalmic Surg 1994; 25: 186-8.
8. Ozkan SB, Can D, Soylev MF, et al. Chemodenervation in treatment of upper eyelid retraction. Ophthalmologica 1997; 211: 387-90.
9. Uddin JM, Davies PD. Treatment of upper eye lid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection. Ophthalmology 2002; 109: 1183-7.